AveXis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch AveXis and buy or sell other stocks, ETFs, and their options commission-free!About AVXS
AveXis , doing business as Novartis Gene Therapies, Inc., is a biotechnology company that specializes in the development and commercialization of gene therapies for patients and families affected by rare and life-threatening neurological genetic diseases. AveXis was acquired by Novartis on May 14, 2018.
CEOSean P. Nolan
CEOSean P. Nolan
Employees—
Employees—
HeadquartersBannockburn, Illinois
HeadquartersBannockburn, Illinois
Founded2010
Founded2010
Employees—
Employees—
AVXS Key Statistics
Market cap8.02B
Market cap8.02B
Price-Earnings ratio-17.65
Price-Earnings ratio-17.65
Dividend yield—
Dividend yield—
Average volume608.43K
Average volume608.43K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$217.94
52 Week high$217.94
52 Week low$65.54
52 Week low$65.54
Stock Snapshot
The current AveXis(AVXS) stock price is $217.83, with a market capitalization of 8.02B. The stock trades at a price-to-earnings (P/E) ratio of -17.65.
On 2025-12-15, AveXis(AVXS) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 608.43K.
The stock's 52-week range extends from a low of $65.54 to a high of $217.94.
The stock's 52-week range extends from a low of $65.54 to a high of $217.94.